Evidence map›Paper›PMID 41258553›Full record

ArticleDiscover oncology2025

Prognostic factors in gastric cancer survivors comparing Cox proportional hazards and machine learning using a Korean National cohort.

Joonki Lee, Aesun Shin

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joonki LeeDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.ORCID http://orcid.org/0000-0002-5643-3062
Aesun ShinDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea. shinaesun@snu.ac.kr.ORCID http://orcid.org/0000-0002-6426-1969

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs the prognosis of gastric cancer has improved, the exploration of prognostic factors has become increasingly important. This study aimed to identify prognostic factors of gastric cancer using machine learning and statistical methods and to compare the effectiveness of different methodologies in identifying prognostic factors.

methodsWe conducted a retrospective cohort study of cancer research data from survivors of gastric cancer in Korea. Patients were followed up from the date of curative treatment of gastric cancer to the date of recurrence, cancer-specific death, or censoring. The Cox proportional hazards, random survival forest, XGBoost, and DeepSurv models were used to calculate the risk of recurrence and cancer-specific death. All the models were trained on 80% of the training set, and the concordance index was used for comparison with 20% of the test set. The SHAP value was used for variable interpretation in the machine learning models.

resultsA total of 11,029 gastric cancer survivors with a median follow-up time of 6.19 years were included. Remnant stomach after gastric cancer treatment, T stage and N stage were the most important features for recurrence and mortality according to both the Cox model and the machine learning model. All the models had a concordance index greater than 0.7 without large differences.

conclusionsThe machine learning model is not inferior to conventional statistical analysis models and offers greater flexibility, especially when statistical assumptions are violated. The key prognostic factors identified through this approach include residual stomach after treatment and cancer stage.

Indexed as

CohortGastric cancerMachine learningPrognosisSHAP.

Identifiers

PMID41258553
PMCPMC12708426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.